| 580 |
Mineralocorticoid Receptor Activation Leading to Increased Body Mass Index |
Théo Jamay |
All rights reserved |
2331: Activation, Mineralocorticoid Receptor
|
2335: Increase, body mass index
|
|
|
| 581 |
Glucocorticoid receptor (GR) activation during development leads to cognitive function (COG) decrease |
Marie-Gabrielle Zurich |
All rights reserved |
122: Increase, Glucocorticoid receptor activation
|
402: Cognitive function, decreased
|
|
|
| 582 |
Inhibition of EphA2 phosphorylation leads to liver damage via the ERK/ MDM2/p53 axis |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 583 |
Vascular endothelial HER2 inhibition disrupts cardiomyocyte calcium homeostasis via EGFR/STAT3/PTX3 axis leading to cardiac contractile dysfunction |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 584 |
SQLE accumulation leads to hepatotoxicity via cholesterol/sphingolipid metabolic disturbance and lysosomal damage |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 585 |
AKT Inhibition blocks the autophagy flow through the PRKAA/AMPK pathway and leads to cardiotoxicity |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 586 |
The increasing accumulation of HMGB1 in the nucleus causes cardiomyocyte death via HMGB1/HSPB1/CCN2 pathway |
Peihua Luo |
All rights reserved |
None
|
None
|
|
|
| 364 |
Thyroperoxidase inhibition leading to altered visual function via decreased eye size |
Lucia Vergauwen |
All rights reserved |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
Under Development |
1.35 |
| 365 |
Thyroperoxidase inhibition leading to altered visual function via altered photoreceptor patterning |
Lucia Vergauwen |
All rights reserved |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
Under Development |
1.35 |